This site is intended for healthcare professionals only

Shingles: the forgotten vaccine during the COVID-19 pandemic

Written by: | Published:

Shingles The shingles vaccine can reduce the incidence of this painful and debilitating condition by 51% in the over-60s

In recent weeks, you’d be forgiven for thinking that there was only one vaccination programme for adults in the UK, the COVID-19 vaccine. Whilst the 2020/21 ‘flu season has just ended with improved uptake rates on the previous season, the same cannot be said for the shingles vaccine or the pneumococcal (PPV23) vaccine. In England uptake rates of the shingles vaccine have plummeted from 61.8% of 70 year olds vaccinated in 2013/14 to 26.5% in 2019/20.1

More on this topic


Please login or register to read the rest of the article and to have access to downloads and comments.


What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Read a free issue from Practice Nursing

Register to read a free issue from our sister publication, Practice Nursing.

Including articles on asthma, diabetes and more. Read your copy.

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.